;
Published: February 07, 2011
;
Most of us have taken a prescription medication at least once in our lifetime. And despite evidence to the contrary, we want to think the drugs our doctors prescribe to us will cure our ills with no negative side effects. After all, the pharmaceutical industry tells us our well-being is of paramount concern.Well, isn’t that special.
;
Many would argue their biggest concern is their bottom line profits. In November of 2010 we discovered that one of the world’s largest drug manufacturers, a subsidiary of GlaxoSmithKline, wasn’t really looking after our well being at all when it distributed adulterated drugs. However, it appears they had an eagle eye on the money. They would’ve likely gotten away with what appears to be gross negligence, too, were it not for one whistleblower. More than likely medications tainted with bacteria, labeled incorrectly, or not the correct strength would have continued to make it to our pharmacies. However, thanks to a tip from a company insider, Cheryl Eckard, a federal investigation ensued and Glaxo has had to pay up BIG.....Continue Reading...
.
.
In Case You Missed It
;
;
.
.
Bad Medicine: The Glaxo Case
January 2, 2011 5:15 PM
January 2, 2011 5:15 PM
;
Drug company whistle-blower Cheryl Eckard tells Scott Pelley about her experience trying to fix problems at a pharmaceutical factory that made her a key figure in a federal lawsuit and a multimillionaire.
.
.
GSK Whistleblower Case Gets TV Airing
Jan 7, 2011
Jan 7, 2011
Pharmaceutical Technology Europe
#GlaxoSmithKline has responded to a recently aired 60 Minutes program about the whistleblower lawsuit that resulted in GSK paying $750 million to settle civil and criminal charges. GSK was accused of manufacturing and selling adulterated drug products to Medicaid and other government health plans. The products were manufactured at the company’s Cidra plant in Puerto Rico, which was closed in 2009 due to declining demand. The plant is no longer owned by GSK. ....Continue Reading....
#GlaxoSmithKline has responded to a recently aired 60 Minutes program about the whistleblower lawsuit that resulted in GSK paying $750 million to settle civil and criminal charges. GSK was accused of manufacturing and selling adulterated drug products to Medicaid and other government health plans. The products were manufactured at the company’s Cidra plant in Puerto Rico, which was closed in 2009 due to declining demand. The plant is no longer owned by GSK. ....Continue Reading....
.
.
No comments:
Post a Comment